Duomed Group acquires GI UK Medical

Duomed Group acquires the British company GI UK. With this step, we are expanding our endoscopy business in a large market with numerous opportunities.

About GI UK

GI UK Medical is an innovative, independent, and dynamic distributor, providing gold-standard products and managed services to the healthcare industry across the UK. Having in-depth experience in rebuilding, growing, and developing numerous organisations in this marketplace, we are now building the UK’s most inventive and creative medical sales organisation.

GI UK Medical is driven by advanced technology and the very best endoscopy accessories, sourced from around the globe. From Endo Essentials to Capsule Endoscopy, Advanced AI Diagnostics and ground-breaking therapeutic systems, we constantly seek to deliver market leading products, to provide our customers with the best possible solutions.

Covering the NHS and private healthcare across the UK and Ireland, based in Leeds, West Yorkshire, GI UK Medical was founded in 2019, and has successfully grown to 14 members of staff in a challenging worldwide environment across the last two years. Our team is united in the understanding that what we do every day makes a difference to our customers and their patients.

​“We are delighted to become a part of the Duomed family. This is a very exciting new partnership, that will provide us with additional valuable support and expertise from a very experienced and successful organisation. Joining forces with Duomed not only makes absolute sense in the current economic climate, but also enables us to grow, not only in the GI space, but also into new healthcare segments.” - Andy Fox, CEO GI UK Medical

​“I am delighted to add GI UK to the Duomed Group and would like to give a very warm welcome to Andy, Lawrence and their team. This acquisition offers many opportunities for both parties in a - for Duomed new - large and very interesting market. In addition to their proven long lasting experience within the endoscopy field, we certainly want to explore opportunities to add other divisions and clinical domains as well. I am sure that a bright future is ahead of us.” - Reinier van der List, CEO Duomed Group